| Literature DB >> 24295452 |
David Rönsberg1, Abdessamad Debbab, Attila Mándi, Vera Vasylyeva, Philip Böhler, Björn Stork, Laura Engelke, Alexandra Hamacher, Richard Sawadogo, Marc Diederich, Victor Wray, WenHan Lin, Matthias U Kassack, Christoph Janiak, Stefanie Scheu, Sebastian Wesselborg, Tibor Kurtán, Amal H Aly, Peter Proksch.
Abstract
Four tetrahydroxanthone dimers (1-4) and four biogenetically related monomers (5-8), including the new derivatives 4-6, were isolated from the endophyte Phomopsis longicolla. The absolute configurations of 2-4 were established for the first time by TDDFT electronic circular dichroism calculations, and that of phomoxanthone A (1) was revised by X-ray crystallography. Phomoxanthone A (1) showed the strongest pro-apoptotic activity when tested against a panel of human cancer cell lines, including cisplatin-resistant cells, whereas it was up to 100-fold less active against healthy blood cells. It was also the most potent activator of murine T lymphocytes, NK cells, and macrophages, suggesting an activation of the immune system in parallel to its pro-apoptotic activity. This dual effect in combating cancer cells could help in fighting resistance during chemotherapy. Preliminary structure-activity studies of isolated compounds and derivatives obtained by semisynthesis (9a-11) hinted at the location of the biaryl axis and the presence of acetyl groups as important structural elements for the biological activity of the studied tetrahydroxanthones.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24295452 DOI: 10.1021/jo402066b
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354